Nagy Habib

Nagy Habib (born 1952) is a British-Egyptian professor of hepato-biliary surgery at Imperial College, London, and is known for devising radio-frequency based liver resection devices which remove liver tumour with minimal blood loss. His work has also focused on stem cells and gene therapy.

Early life and education Nagy Habib was born in Cairo, Egypt, 1952. He trained under both and the transplant surgeon Thomas Starzl.

Career His work has focused on stem cells and gene therapy. He led the first clinical trial in the use of oncolytic adenoviruses for the treatment of liver cancer. It was carried out by means of a locally restricted injection into the main blood vessel to the liver. The findings were published in 2001.

In 2003 he was appointed professor of hepato-biliary surgery at Imperial College, London. In June 2007 he was appointed pro-rector for Commercial Affairs at Imperial. He devised the Habib RF device using the Habib needle, which has a modified version called the Habib 4X.

MiNA Therapeutics, a biotechnology company dealing in small activating RNA technology was co-founded by Habib and his son Robert.

Awards and honours He was awarded the Takreem award in December 2012, for his work in liver cancer and radio-frequency based liver resection.

Selected publications Articles (Co-author) (Co-author) (Co-author) (Co-author)

Books